Literature DB >> 1775175

Molecular cloning and sequence analysis of a calcium-activated neutral protease (calpain) from Schistosoma mansoni.

S R Karcz1, R B Podesta, A A Siddiqui, G A Dekaban, G H Strejan, M W Clarke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1775175     DOI： 10.1016/0166-6851(91)90078-k

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  11 in total

1.  Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.

Authors:  Afzal A Siddiqui; Troy Phillips; Hugues Charest; Ron B Podesta; Martha L Quinlin; Justin R Pinkston; Jenny D Lloyd; Michelle Paz; Rachael M Villalovos; Janet Pompa
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Evolution of EF-hand calcium-modulated proteins. III. Exon sequences confirm most dendrograms based on protein sequences: calmodulin dendrograms show significant lack of parallelism.

Authors:  S Nakayama; R H Kretsinger
Journal:  J Mol Evol       Date:  1993-05       Impact factor: 2.395

3.  Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Workineh Torben; Mayeen U Alam; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; David W Carey; Darrick Carter; Steven G Reed; Afzal A Siddiqui
Journal:  Vaccine       Date:  2014-01-04       Impact factor: 3.641

4.  Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum.

Authors:  R Zhang; A Yoshida; T Kumagai; H Kawaguchi; H Maruyama; T Suzuki; M Itoh; M El-Malky; N Ohta
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 5.  Structure and physiological function of calpains.

Authors:  H Sorimachi; S Ishiura; K Suzuki
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

6.  Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Workineh Torben; Mayeen U Alam; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; David W Carey; Darrick Carter; Steven G Reed; Afzal A Siddiqui
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

7.  Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni.

Authors:  G Ahmad; W Torben; W Zhang; M Wyatt; A A Siddiqui
Journal:  Parasite Immunol       Date:  2009-03       Impact factor: 2.280

8.  Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald C Kennedy; Afzal A Siddiqui
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

9.  Complement plays a minimal role in Sm-p80-mediated protection against Schistosoma mansoni.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Mayeen U Alam; Richard Winn; Workineh Torben; Loc Le; Kory A Tillery; Afzal A Siddiqui
Journal:  Hum Vaccin Immunother       Date:  2013-12-27       Impact factor: 3.452

Review 10.  Novel therapeutic and prevention approaches for schistosomiasis: review.

Authors:  Rashika A F El Ridi; Hatem A-M Tallima
Journal:  J Adv Res       Date:  2012-06-23       Impact factor: 10.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.